咨询与建议

限定检索结果

文献类型

  • 2 篇 会议
  • 1 篇 期刊文献

馆藏范围

  • 3 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 3 篇 医学
    • 3 篇 临床医学

主题

  • 1 篇 fpr1
  • 1 篇 immune response
  • 1 篇 dendritic cells
  • 1 篇 melanoma
  • 1 篇 clinical
  • 1 篇 chemotherapy
  • 1 篇 al.

机构

  • 2 篇 gustave roussy c...
  • 2 篇 inserm u1015
  • 1 篇 inserm u1015 vil...
  • 1 篇 gustave roussy c...
  • 1 篇 center of clinic...
  • 1 篇 suzhou institute...
  • 1 篇 inserm u1138 equ...
  • 1 篇 equipe labellise...
  • 1 篇 faculty of medic...
  • 1 篇 suzhou institute...

作者

  • 3 篇 laurence zitvoge...
  • 1 篇 romain daillère
  • 1 篇 lisa derosa
  • 1 篇 yuting ma
  • 1 篇 marie vetizou
  • 1 篇 jonathan m. pitt
  • 1 篇 erika vacchelli
  • 1 篇 guido kroemer

语言

  • 3 篇 英文
检索条件"作者=Laurence Zitvogel"
3 条 记 录,以下是1-10 订阅
排序:
Fecal microbiota transplantation: can it circumvent resistance to PD-1 blockade in melanoma?
收藏 引用
Signal Transduction and Targeted Therapy 2021年 第6期6卷 1630-1631页
作者: Lisa Derosa laurence zitvogel Gustave Roussy Comprehensive Cancer Institute ClinicobiomeVillejuifFrance Faculty of Medicine Universite Paris SaclayLe Kremlin-BicetreFrance INSERM U1015 VillejuifFrance Equipe labellisee par la Ligue contre le cancer VillejuifFrance Center of Clinical Investigations in Biotherapies of Cancer(CICBT)BIOTHERIS VillejuifFrance Suzhou Institute for Systems Medicine Chinese Academy of Medical SciencesSuzhouChina
In two recent articles,Baruch et al.1 and Davar et al.2 bring up the first proof-of-concept that fecal microbiota transplantation(FMT)transfer clinical benefit in metastatic melanoma patients primarily resistant to im... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
FPR1 acts as a checkpoint for chemotherapy triggered antitumor response
FPR1 acts as a checkpoint for chemotherapy triggered antitum...
收藏 引用
第十届全国免疫学学术大会
作者: Yuting MA Erika Vacchelli laurence zitvogel Guido Kroemer INSERM U1138 Equipe 11 Centre de Recherche des Cordeliers Suzhou Institute of Systems Medicine Chinese Academy of Medical Sciences Gustave Roussy Cancer Campus INSERM U1015
Accumulating evidence suggests that anticancer chemotherapeutic success relies on the elicitation of a durable tumortargeting immune response following"immunogenic"tumor cell ***-of-function mutations in immune-relate... 详细信息
来源: cnki会议 评论
Antitumor efficacy of anti-CTLA4 antibody is dependant on gut microbiota.
Antitumor efficacy of anti-CTLA4 antibody is dependant on gu...
收藏 引用
第十届全国免疫学学术大会
作者: Marie Vetizou Jonathan M. Pitt Romain Daillère laurence zitvogel Gustave Roussy Cancer Campus INSERM U1015
The cytotoxic T lymphocyte antigen-4(CTLA-4)-blocking antibody ipilimumab is an FDA and EMEA-approved treatment for metastatic melanoma,which induces immune-mediated long-term control in 15%of ***,ipilimumab also resu...
来源: cnki会议 评论